Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.110133 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.110133 32758904!7380211!32758904     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 144 (ä): 110133 Nephropedia Template TP {{tp|p=32758904|t=2020. N-acetycysteine: A potential therapeutic agent in COVID-19 infection |pdf=|usr=}}{{32758904}} gab.com Text N-acetycysteine: A potential therapeutic agent in COVID-19 infection JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32758904 #FOAvip COVID-19 is an overwhelming pandemic which has shattered the whole world. Lung injury being the main clinical manifestation, it is likely to cause COPD (chronic obstructive pulmonary disease) and ARDS (acute respiratory distress syndrome). The possible cause behind this might be redox imbalance due to viral infection. Elevation in Glutathione (GSH) levels by administration of its promolecule might be effective. N-acetylcysteine is one such drug with potency to scavenge Reactive Oxygen Species, least side effects, and an effective precursor of glutathione. Consequently we hypothesize that N-acetylcysteine along with the conventional treatment may be treated as a potential therapeutic solution in cases of COVID-19 patients. Twit Text FOAVip N-acetycysteine: A potential therapeutic agent in COVID-19 infection ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32758904 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32758904 #FOAvip English Wikipedia <ref>{{Cite pmid|32758904}}</ref> N-acetycysteine: A potential therapeutic agent in COVID-19 infection #MMPMID32758904 Jaiswal N; Bhatnagar M; Shah H Med Hypotheses 2020[Nov]; 144 (ä): 110133 PMID32758904show ga COVID-19 is an overwhelming pandemic which has shattered the whole world. Lung injury being the main clinical manifestation, it is likely to cause COPD (chronic obstructive pulmonary disease) and ARDS (acute respiratory distress syndrome). The possible cause behind this might be redox imbalance due to viral infection. Elevation in Glutathione (GSH) levels by administration of its promolecule might be effective. N-acetylcysteine is one such drug with potency to scavenge Reactive Oxygen Species, least side effects, and an effective precursor of glutathione. Consequently we hypothesize that N-acetylcysteine along with the conventional treatment may be treated as a potential therapeutic solution in cases of COVID-19 patients. |*COVID-19 Drug Treatment[MESH] |Acetylcysteine/chemistry/*therapeutic use[MESH] |Antioxidants/therapeutic use[MESH] |Glutathione/*metabolism[MESH] |Humans[MESH] |Oxidation-Reduction[MESH] |Oxidative Stress[MESH] |Pulmonary Disease, Chronic Obstructive/virology[MESH] |Reactive Oxygen Species/metabolism[MESH]N-acetycysteine: A potential therapeutic agent in COVID-19 infection (epmc).pdf DeepDyve Pubget Overpricing